Similar articles

• The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.

  Mukerjee D, Yap LB, Ong V, Denton CP, Howells K, Black CM, Coghlan JG. Mukerjee D, et al. Ann Rheum Dis. 2004 Dec;63(12):1627-31. doi: 10.1136/ard.2003.015289. Ann Rheum Dis. 2004. PMID: 15547087 Free PMC article.
• Screening and therapy of pulmonary hypertension in systemic sclerosis.

  Bull TM. Bull TM. Curr Opin Rheumatol. 2007 Nov;19(6):598-603. doi: 10.1097/BOR.0b013e3282ec67d4. Curr Opin Rheumatol. 2007. PMID: 17917541 Review.
• [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].

  Hunzelmann N, Riemekasten G. Hunzelmann N, et al. Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S325-7. doi: 10.1055/s-2006-957203. Dtsch Med Wochenschr. 2006. PMID: 17139598 Review. German.
• Is exercise-induced pulmonary hypertension ready for prime time in systemic sclerosis?

  Steen VD, Champion H. Steen VD, et al. Int J Clin Pract Suppl. 2011 Jan;(169):1-3. doi: 10.1111/j.1742-1241.2010.02603.x. Int J Clin Pract Suppl. 2011. PMID: 21176008 No abstract available.
• Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.

  Robertson L, Pignone A, Kowal-Bielecka O, Fiori G, Denton CP, Matucci-Cerinic M. Robertson L, et al. Ann Rheum Dis. 2005 Jun;64(6):804-7. doi: 10.1136/ard.2004.026427. Ann Rheum Dis. 2005. PMID: 15897302 Free PMC article. No abstract available.